These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8726633)

  • 1. Effects of systemic treatment with statins on skin barrier function and stratum corneum water-holding capacity.
    Brazzelli V; Distante F; Perani G; Berardesca E
    Dermatology; 1996; 192(3):214-6. PubMed ID: 8726633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of systemic treatment with cholesterol-lowering drugs on the skin barrier function in humans.
    Ramsing D; Agner E; Malinowski J; Meibom J; Agner T
    Acta Derm Venereol; 1995 May; 75(3):198-201. PubMed ID: 7653179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A; Rovellini A; Fiorenza AM; Sommariva D
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia.
    Cutler N; Sramek J; Veroff A; Block G; Stauffer L; Lines C
    Br J Clin Pharmacol; 1995 Mar; 39(3):333-6. PubMed ID: 7619678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins do more than just lower cholesterol.
    Vaughan CJ; Murphy MB; Buckley BM
    Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463
    [No Abstract]   [Full Text] [Related]  

  • 9. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
    Steinhagen-Thiessen E
    Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged occlusion on stratum corneum barrier function and water holding capacity.
    Fluhr JW; Lazzerini S; Distante F; Gloor M; Berardesca E
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):193-8. PubMed ID: 10420139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
    Alessandri C; Peverini F
    Minerva Med; 1992 Nov; 83(11):677-93. PubMed ID: 1461539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary glucosylceramide improves skin barrier function in hairless mice.
    Tsuji K; Mitsutake S; Ishikawa J; Takagi Y; Akiyama M; Shimizu H; Tomiyama T; Igarashi Y
    J Dermatol Sci; 2006 Nov; 44(2):101-7. PubMed ID: 17000082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin, pravastatin and lovastatin: three options for lowering cholesterol.
    Holdcroft C
    Nurse Pract; 1993 May; 18(5):56-7. PubMed ID: 8355901
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic differences in barrier and hygroscopic properties between normal and cosmetic dry skin. I. Enhanced barrier analysis with sequential tape-stripping.
    Lu N; Chandar P; Tempesta D; Vincent C; Bajor J; McGuiness H
    Int J Cosmet Sci; 2014 Apr; 36(2):167-74. PubMed ID: 24397786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypercholesterolemia: therapeutic approach].
    Alessandri C; Peverini F
    Clin Ter; 1991 Jun; 137(6):373-97. PubMed ID: 1832610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.